Factors associated with recurrence and mortality in central line-associated bloodstream infections: a retrospective cohort study.
Luis E HuertaGeorge E NelsonThomas G StewartTodd W RicePublished in: Critical care (London, England) (2018)
Longer antimicrobial treatment duration in patients with HA-CLABSIs is associated with improved recurrence-free survival during the first 60 days after infection. This effect appears to plateau after 15 days of treatment. Prospective studies are needed to definitively determine the optimal antimicrobial treatment duration for CLABSIs.